Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-mvc sequences in untreated 
neuroblastomas correlates with advanced disease stage. Science 224;1 121-1 124, 1984. 
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple 
copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1 1 1 1-1 1 16, 1985. 
Slamon DJ, Boone TC, Seeger RC, Keith DE, Chazin V, Lee HC, Souza LM. Identification and 
characterization of the protein encoded by the human N-myc oncogene. Science 232:768-772, 1986. 
Reynolds CP, Seeger RC, Vo DD, Black AT, Wells J, Ugelstad J. Model system for removing neuroblastoma 
cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 5882-5886, 
1986. 
Brodeur GM, Hayes FA, Green AA, Casper J, Wasson J, Wallach S, Seeger RC. Consistent N-myc copy 
number in simultaneous or consecutive neuroblastoma samples from 60 individual patients. Cancer Res 
47:4248-4253, 1987. 
Brodeur GM, Seeger RC, (Chairmen); Barrett A, Berthold F, Castleberry RP, D’Angio G, DeBernardi B, 
Evans AE, Favrot M, Freeman AI, Haase G, Hartmann O, Hayes A,'Helson L, Pinkerton CR, Pritchard J, 
Sawada T, Siegel S, Smith El, Tsuchida Y, Voute PA (contributors). International criteria for diagnosis, 
staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881, 1988. 
Moss TJ, Rosenblatt HM, Seeger RC. Expression of a developmental stage specific antigen by neuronal 
precursor cells of human fetal cerebellum. J Neuroimm 20:3-14, 1988. 
Hsiao RJ, Seeger RC, Yu AL, O’Connor DT. Chromogranin A in children with neuroblastoma: serum 
concentration parallels disease stage and predicts survival. J Clin Inves 20:3-14, 1990. 
Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich 
F, Strahler JR, et al. High levels of pl9/nm23 protein in neuroblastoma are associated with advanced stage 
disease and with N-myc gene amplification. J Clin Inves 88:1:341-345, 1991. 
Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. Prognostic value of 
immunocytologic detection of bone marrow metastases in neuroblastoma. New Eng J Med 324:219-226, 1991 . 
Tanaka T, Slamon D, Shimada H, Shimoda H, Fujisawa T, Ida N, Seeger RC, A significant association of 
Ha-r< 2 S p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases. Cancer 
68:6:1296-1302, 1991. 
Wada RK, Seeger RC, Reynolds CP, Alloggiamento T, Yamashiro JM, Ruland CR, Black AC, Rosenblatt JD. 
Functional studies of the N-myc promoter in neuroblastoma cells. Oncogene 1:11 1-717, 1992, 
Leone A, Seeger RC, Arboleda MJ, Slamon DJ, Stram D, Steeg PS. Evidence for nm23 overexpression, DNA 
amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865, 1992. 
Crabbe DG, Peters J, Seeger RC. Rapid Detection of MYCN gene amplification in neuroblastomas using the 
polymerase chain reaction (PCR). Diag Mol Path 1:229-234, 1992. 
Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. Aggressive neuroblastomas lack high affinity 
nerve growth factor receptors. JNCI 85:377-384, 1993. 
Srivatsan ES, Lin Ying K, Seeger RC. Deletion of chromosome 1 1 sequences in neuroblastoma. Genes Chrom 
Cancer 7:32-37, 1993. 
Seeger RC, and Reynolds CP. Neuroblastoma. In: Holland JF, Frei E III, Base RC Jr., Kufe DW, Morton 
DL. Weichsenbaum RR, eds. Philadelphia: Lea & Febiger, Cancer Medicine 39(5):2172-2184, 1993. 
Recombinant DNA Research, Volume 19 
[125] 
